NEW YORK, Aug. 20 - Pharsight today said that Organon will use its clinical trial-modeling -simulation technology to help it develop better clinical trials and improve its drug-development process.
The deal, an extension of an existing collaboration, may extend further if both sides are happy with the outcome of this part.
Click here for more information.